Screening for Type 2 Diabetes Mellitus in Primary Care
DOI:
https://doi.org/10.51481/amc.v48i1.216Keywords:
Diabetes Mellitus type 2, early detection, screeningAbstract
Introduction:Type 2 Diabetes mellitus today must beconsidered a public health problem in Costa Rica, since ithas a great impact in the quality of life of the patients andtheir families, due to its chronic complications and also inthe Social Security System due to its costs. Early diagnosisand prompt treatment decrease the burden of its complica-tions.Therefore, Diabetes screening in a high risk popu-lation should be considered beneficial. The purpose of thisstudy was to evaluate the results of a screening interventionin primary care in high risk persons.
Methodology:Screening was implemented along the year2000 in the adult population with at least one risk factor of 6 Primary Health Centers, incorporated in the daily routineof the primary health care attention. Four different strate-gies were used: the ""opportunistic"" during the regular med-ical consultation, a selective one during home visits, pro-grammed, directed to captive groups or social organiza-tions, and ""Jornadas"" during community or national healthfairs.
Results:During the year 2000, 173 new diabetic patientswere registered by the health centers, either they werenewly diagnosed or where known diabetics that lived in thearea, but were not following control there. The predomi-nant strategy was the ""oportunístic"", relaying the responsi-bility especially upon the physician. The programed strat-egy in ""Jornadas"" was undertaken during Health Fairs ofthe Primary care centers and during the World DiabetesDay, the 14 of November. The selective strategy was notperform systematically since there were no glucometers forthe primary health care assistant that does home visits. Theproper registration or ""coverage"" of the diabetic patients ofthe Health Center Area increased from 50% in1999 to70.2% in 2000, considering the former as the percentage ofdiabetic patients under control or registered divided by thenumber of diabetics accounted for each health center, con-sidering a prevalence of 5% of the population 20 years andolder.
Conclusion:Costa Rica can accomplish an early detectionand prompt treatment of Diabetes mellitus type 2 by screen-ing intervention of high risk individuals. This is alreadybeing done with through the ""opportunistic"" strategy. Thisstudy shows that this strategy can be effectively implement-ed and that it can be operational with little effort. Our HealthCare System, based in a primary health care setting, is inposition to develop other screening strategies that could givehigher coverage with lower costs: such as home visit screen-ing by the primary health assistant. Logistically the condi-tions are given, however this intervention requires a commu-nity study to determine its real cost-benefit. If the resultswere favorable, such intervention could be implemented aspart of diabetes care in the whole country, making CostaRica a pioneer in the world in this kind of intervention.
Downloads
References
King H, Aubert R, Herman W. Global burden of Diabetes, 1995-2025, prevalence, numerical estimates and projections. DiabetesCare 1998; 21:1414-1431.
Trejos A, Ortega A. El envejecimiento de la población costarricense.Rev Médica Hosp. Nacional de Niños (Costa Rica) 1985; 20:35-44
Morice A, Roselló M, Araúz AG, Sánchez G, Padilla G. Diabetes mel-litus en Costa Rica: un análisis interdisciplinario. Capítulo IV:Prevalencia de Diabetes mellitus en Costa Rica. Serie de documentostécnicos. Instituto de Investigación y Enseñanza en nutrición y salud.Costa Rica, agosto 1999.
Tan H, Maclean DR. Epidemiology of diabetes mellitus in Canada.Clin Invest Med 1995;18: 240-246.
Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE,Little RR, et al. Prevalence of diabetes, impaired fasting glucose, andimpaired glucose tolerance in U. S. Adults: the Third National Healthand Nutrition Examination Survey 1988-1994. Diabetes Care 1998;21: 518-524.
Aiello LP, Gardner TW, King GL, Blanken-Ship G, Cavallerano JD,Ferris Fl et al. Diabetic retinopathy (Technical Reviews). DiabetesCare 1998; 21:143-156.
Harris MI, Klein R, Cowie CC, Rowland M, Burd-Holt DD. Is therisk of diabetic retinopathy greater in non-Hispanic blacks anMexican Americans that in non-Hispanic whites with type 2 diabetes,a U.S population Study. Diabetes Care 1998; 21:1230-1235.
Rajala U, Laakso M, Qiao Q, Keinanen-Kiukaanniemi S. Prevalenceof retinopathy in people with diabetes, impaired glucose tolerance,and normal glucose tolerance. Diabetes Care 1998;21: 1664-1669.
Ballard DJ, Humphrey LL, Melton LJ, Frohnert PP, Chu PC,O Fallon WM et al. Epidemiology of persistent proteinuria in type 2diabetes mellitus: population-based study in Rochester, Minnesota.Diabetes 1988; 37:405-412.
Klein R, Klein BEK, Moss SE. Prevalence of microalbumnuria inolder-onset diabetes. Diabetes Care 1993;16: 1325-1330.
Lehtinen JM, Uusitupa M, Siitoneno, Pyorala K. Prevalence of neu-ropathy in newly diagnosed NIDDM and nondiabetic control sub-jects. Diabetes 1989; 38:1308-1313.
Thomas P. Classification, differential diagnosis, and staging of dia-betic peripheral neuropathy. Diabetes Care 1997; 46: S54-S57.
Turner R, Cull C, Holman R. United Kingdom prospective diabetesstudy 17: a 9 year update of a randomized, controlled trial on theeffect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996; 124:136-145.
Harris ML. Undiagnosed NIDDM: clinical and public health issues.Diabetes Care1993;16: 642-652
.15. Harris MI. Sreening for NIDDM: Why is there no national program?Diabetes Care 1994; 17:440-444.
Cowie CC, Harris MI, Eberhardt MS. Frecquency and determinantsof screening for diabetes in the U. S. Diabetes Care 1994;17: 1158-1163.
American Diabetes Association: Screening for type 2 diabetes.Diabetes Care 2000; 23 S20-S23.
Engelgau M, Venkat K.M, Herman, WH. Sreening for type 2 dia-betes, Diabetes Care 2000; 23 1563-1580.
Harris MI, Klein R, Welborn Ta,Knuiman MW. Onset of NIDDMoccurs at least 4-7 years before diagnosis. Diabetes Care 1992;15:815-819.
Expert committee on the diagnosis and classification of diabetes mel-litus. Report of the expert committee on the diagnosis and classifica-tion of diabetes mellitus. Diabetes Care 1997;20: 1183-1197.
UK Prospective Diabetes Study (UKPDS) group. Intensive bloodglucose control with sulphonylureas or insulin compared with con-ventional treatment and risk of complications in patients with type 2diabetes. (UKPDS 33) Lancet 1998; 352:837-853.
Reney CC, Kirk JK. Performance of three blood glucose meters. AnnPharmacother 2000; 34:317-21.
Caja Costarricense de Seguro Social, Plan de atención a la salud de la personas 2001-2006, pag 100, San José, Costa Rica, 2001
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)



